Filing Flows

Filing Flows › Thermo Fisher Scientific (TMO) › Q3 2025

Thermo Fisher Scientific (TMO) Q3 2025 earnings results (third quarter 2025)

10-Q filed Oct 31, 2025

Thermo Fisher Scientific (TMO) reported revenue of $11.1B for the third quarter 2025 (Q3 2025), +5% from a year earlier and +2% from the quarter before. Operating margin was 17.5%, net earnings $1.6B (14.6% of revenue).

Revenue$11.1B
Year over year+5%
Quarter over quarter+2%
Operating margin17.5%
Net earnings$1.6B

Thermo Fisher Scientific, Q3 2025: revenue $11.1B (+5% year over year), operating margin 17.5%, net earnings $1.6B, operating cash flow $2.2B. The chart follows the revenue to costs, profit and cash.

Q3 2025AmountQ/QY/Y
Revenue$11.1B+2%+5%
Operating profit$1.9B+6%+6%
Net earnings$1.6B+0.2%-0.5%
Operating cash flow$2.2B+60%+3%
Free cash flow$1.8B+66%-3%

What changed

Revenue was $11.1B in Q3 2025, up 5% year over year and up 2% from the previous quarter. Laboratory Products and Biopharma Services was the largest line at 53% of revenue. Laboratory Products and Biopharma Services added $0.23B year over year (up 4%), 43% of the total change.

Operating profit was $1.9B, a 17.5% margin (up 0.1 points year over year). Of the extra revenue versus a year earlier, 20% reached operating profit, above the 17% margin then. Total costs grew 5% against revenue growth of 5%. Net earnings were $1.6B, down 1% year over year. The effective tax rate was 11.3%.

Operating cash flow was $2.2B (up 3% year over year), 138% of net earnings. Non-cash charges added back $0.66B of depreciation and amortization and $0.07B of share-based compensation. Working capital and other items used $0.11B. Capital expenditures of $0.40B left free cash flow of $1.8B.

Questions

What was Thermo Fisher Scientific's revenue in the third quarter 2025?

Thermo Fisher Scientific (TMO) reported revenue of $11.1B for the third quarter 2025 (Q3 2025), +5% from a year earlier and +2% from the quarter before.

Was Thermo Fisher Scientific profitable in the third quarter 2025?

Operating profit was $1.9B (17.5% of revenue) and net earnings $1.6B.

Open the interactive Sankey →

Source: Thermo Fisher Scientific 10-Q on SEC EDGAR.